Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 13Gastrointestinal 3Dermatologic 3Thoracic 2Genitourinary 2Plasma cell 1Head & Neck 1Gynecologic 1Breast 1

Conditions

Melanoma 783Carcinoma, Non-Small-Cell Lung 170Skin Neoplasms 154Neoplasms 106Neoplasm Metastasis 100Colorectal Neoplasms 97Carcinoma, Renal Cell 95Uveal Melanoma 92Breast Neoplasms 88Squamous Cell Carcinoma of Head and Neck 85Carcinoma, Basal Cell 83Lung Neoplasms 81Ovarian Neoplasms 79Sarcoma 67Lymphoma, T-Cell, Cutaneous 66Carcinoma, Merkel Cell 66Stomach Neoplasms 58Pancreatic Neoplasms 58Head and Neck Neoplasms 55Carcinoma, Hepatocellular 53Uterine Cervical Neoplasms 52Urinary Bladder Neoplasms 50Esophageal Neoplasms 44Prostatic Neoplasms 43Triple Negative Breast Neoplasms 42Endometrial Neoplasms 41Carcinoma, Squamous Cell 39Brain Neoplasms 39Carcinoma, Transitional Cell 37Lymphoma 35

Interventions

pembrolizumab 1Radiation 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Liposarcoma, Myxoid × Dermatologic × 1 year × Clear all
NCT03132922 2026-06-04

MAGE-A4ᶜ¹º³²T for Multi-Tumor

USWM, LLC (dba US WorldMeds)

Phase 1 Active not recruiting
71 enrolled 20 charts
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Sarcoma, Synovial, Liposarcoma, Myxoid

NCT05492682 2026-05-12

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Valo Therapeutics Oy

Phase 1 Recruiting
15 enrolled
BreastDermatologicGastrointestinalSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Sarcoma, Osteosarcoma, Sarcoma, Synovial, Colorectal Neoplasms, Liposarcoma, Myxoid, Triple Negative Breast Neoplasms

NCT05120271 2025-12-05

DUET-1

Sotio Biotech Inc.

Phase 1/2 Active not recruiting
7 enrolled
DermatologicGastrointestinalSarcoma

Carcinoma, Hepatocellular, Carcinoma, Merkel Cell, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡